F. Luis

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Ahn， Jin Hee, S. Loi, D. Cescon, 2020, The Lancet.

FRI0269 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHÇET’S DISEASE. NATIONAL MULTICENTER STUDY OF 177 CASES

F. Romero, J. Nolla, S. Castañeda, 2019, Poster Presentations.

Once-Daily Saquinavir-hgc Plus Low-Dose Ritonavir (1200/100 mg) in HIV-Infected Pregnant Women: Pharmacokinetics and Efficacy

F. Luis, 2003 .